vs
Side-by-side financial comparison of Andersons, Inc. (ANDE) and CORVEL CORP (CRVL). Click either name above to swap in a different company.
Andersons, Inc. is the larger business by last-quarter revenue ($329.5M vs $235.6M, roughly 1.4× CORVEL CORP). Andersons, Inc. runs the higher net margin — 20.5% vs 10.3%, a 10.2% gap on every dollar of revenue. On growth, CORVEL CORP posted the faster year-over-year revenue change (3.4% vs -2.4%). CORVEL CORP produced more free cash flow last quarter ($35.2M vs $-77.1M). Over the past eight quarters, CORVEL CORP's revenue compounded faster (6.6% CAGR vs -1.8%).
The Andersons, Inc. is an American agribusiness established in 1947, that began as Andersons Truck Terminal (ATT) in the 1940s for the grain industry, headquartered in Maumee, Ohio. It is a diversified company rooted in agriculture that conducts business in the commodity merchandising, renewables, and plant nutrient sectors.
Corvel Corp is a U.S.-headquartered provider of integrated workers’ compensation, healthcare management, and risk mitigation solutions. It serves insurance carriers, self-insured employers, and public sector clients, delivering services to control healthcare costs, improve care outcomes, and optimize administrative operations.
ANDE vs CRVL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $329.5M | $235.6M |
| Net Profit | $67.4M | $24.2M |
| Gross Margin | 70.3% | 23.3% |
| Operating Margin | 26.6% | 13.7% |
| Net Margin | 20.5% | 10.3% |
| Revenue YoY | -2.4% | 3.4% |
| Net Profit YoY | 49.6% | 1.7% |
| EPS (diluted) | — | $0.47 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $329.5M | $235.6M | ||
| Q3 25 | $295.8M | $239.6M | ||
| Q2 25 | $535.0M | $234.7M | ||
| Q1 25 | $370.8M | $231.5M | ||
| Q4 24 | $337.5M | $228.0M | ||
| Q3 24 | $231.9M | $224.4M | ||
| Q2 24 | $492.5M | $211.7M | ||
| Q1 24 | $341.4M | $207.2M |
| Q4 25 | $67.4M | $24.2M | ||
| Q3 25 | $20.1M | $27.9M | ||
| Q2 25 | $7.9M | $27.2M | ||
| Q1 25 | $284.0K | $26.4M | ||
| Q4 24 | $45.1M | $23.8M | ||
| Q3 24 | $27.4M | $23.4M | ||
| Q2 24 | $36.0M | $21.6M | ||
| Q1 24 | $5.6M | $19.5M |
| Q4 25 | 70.3% | 23.3% | ||
| Q3 25 | 57.8% | 24.3% | ||
| Q2 25 | 29.6% | 24.2% | ||
| Q1 25 | 41.2% | 25.0% | ||
| Q4 24 | 63.1% | 23.2% | ||
| Q3 24 | 76.4% | 22.6% | ||
| Q2 24 | 35.6% | 22.7% | ||
| Q1 24 | 37.6% | 20.9% |
| Q4 25 | 26.6% | 13.7% | ||
| Q3 25 | 8.7% | 15.0% | ||
| Q2 25 | 4.6% | 15.0% | ||
| Q1 25 | 0.9% | 14.4% | ||
| Q4 24 | 19.9% | 13.5% | ||
| Q3 24 | 26.8% | 12.8% | ||
| Q2 24 | 11.6% | 13.2% | ||
| Q1 24 | 4.1% | 10.9% |
| Q4 25 | 20.5% | 10.3% | ||
| Q3 25 | 6.8% | 11.6% | ||
| Q2 25 | 1.5% | 11.6% | ||
| Q1 25 | 0.1% | 11.4% | ||
| Q4 24 | 13.4% | 10.4% | ||
| Q3 24 | 11.8% | 10.4% | ||
| Q2 24 | 7.3% | 10.2% | ||
| Q1 24 | 1.6% | 9.4% |
| Q4 25 | — | $0.47 | ||
| Q3 25 | $0.59 | $0.54 | ||
| Q2 25 | $0.23 | $0.52 | ||
| Q1 25 | $0.01 | $-1.23 | ||
| Q4 24 | $1.31 | $0.46 | ||
| Q3 24 | $0.80 | $1.35 | ||
| Q2 24 | $1.05 | $1.25 | ||
| Q1 24 | $0.16 | $1.12 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $98.3M | $230.0M |
| Total DebtLower is stronger | $560.0M | — |
| Stockholders' EquityBook value | $1.2B | $375.7M |
| Total Assets | $3.7B | $644.8M |
| Debt / EquityLower = less leverage | 0.45× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $98.3M | $230.0M | ||
| Q3 25 | — | $207.5M | ||
| Q2 25 | — | $202.0M | ||
| Q1 25 | — | $170.6M | ||
| Q4 24 | $561.8M | $162.9M | ||
| Q3 24 | — | $138.3M | ||
| Q2 24 | — | $131.9M | ||
| Q1 24 | — | $105.6M |
| Q4 25 | $560.0M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $608.2M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $1.2B | $375.7M | ||
| Q3 25 | $1.2B | $362.8M | ||
| Q2 25 | $1.4B | $342.5M | ||
| Q1 25 | $1.4B | $322.0M | ||
| Q4 24 | $1.4B | $300.9M | ||
| Q3 24 | $1.3B | $282.8M | ||
| Q2 24 | $1.3B | $263.9M | ||
| Q1 24 | $1.3B | $247.6M |
| Q4 25 | $3.7B | $644.8M | ||
| Q3 25 | $3.3B | $611.7M | ||
| Q2 25 | $3.4B | $597.4M | ||
| Q1 25 | $3.8B | $546.0M | ||
| Q4 24 | $4.1B | $538.8M | ||
| Q3 24 | $3.4B | $518.6M | ||
| Q2 24 | $3.3B | $486.2M | ||
| Q1 24 | $3.3B | $454.7M |
| Q4 25 | 0.45× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.45× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-6.2M | $46.1M |
| Free Cash FlowOCF − Capex | $-77.1M | $35.2M |
| FCF MarginFCF / Revenue | -23.4% | 14.9% |
| Capex IntensityCapex / Revenue | 21.5% | 4.7% |
| Cash ConversionOCF / Net Profit | -0.09× | 1.91× |
| TTM Free Cash FlowTrailing 4 quarters | $-56.1M | $104.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-6.2M | $46.1M | ||
| Q3 25 | $233.9M | $25.0M | ||
| Q2 25 | $299.3M | $55.0M | ||
| Q1 25 | $-350.0M | $22.9M | ||
| Q4 24 | $268.8M | $41.6M | ||
| Q3 24 | $-2.1M | $22.3M | ||
| Q2 24 | $304.4M | $40.4M | ||
| Q1 24 | $-239.6M | $15.2M |
| Q4 25 | $-77.1M | $35.2M | ||
| Q3 25 | $167.0M | $15.3M | ||
| Q2 25 | $250.5M | $39.5M | ||
| Q1 25 | $-396.6M | $14.3M | ||
| Q4 24 | $212.9M | $32.1M | ||
| Q3 24 | $-40.0M | $12.4M | ||
| Q2 24 | $275.8M | $32.8M | ||
| Q1 24 | $-266.4M | $5.2M |
| Q4 25 | -23.4% | 14.9% | ||
| Q3 25 | 56.5% | 6.4% | ||
| Q2 25 | 46.8% | 16.8% | ||
| Q1 25 | -106.9% | 6.2% | ||
| Q4 24 | 63.1% | 14.1% | ||
| Q3 24 | -17.2% | 5.5% | ||
| Q2 24 | 56.0% | 15.5% | ||
| Q1 24 | -78.0% | 2.5% |
| Q4 25 | 21.5% | 4.7% | ||
| Q3 25 | 22.6% | 4.1% | ||
| Q2 25 | 9.1% | 6.6% | ||
| Q1 25 | 12.6% | 3.7% | ||
| Q4 24 | 16.6% | 4.2% | ||
| Q3 24 | 16.3% | 4.4% | ||
| Q2 24 | 5.8% | 3.6% | ||
| Q1 24 | 7.8% | 4.8% |
| Q4 25 | -0.09× | 1.91× | ||
| Q3 25 | 11.61× | 0.90× | ||
| Q2 25 | 38.10× | 2.02× | ||
| Q1 25 | -1232.46× | 0.87× | ||
| Q4 24 | 5.96× | 1.75× | ||
| Q3 24 | -0.08× | 0.95× | ||
| Q2 24 | 8.46× | 1.87× | ||
| Q1 24 | -42.94× | 0.78× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ANDE
| Specialty And Primary Nutrients | $137.1M | 42% |
| Premium Ingredients | $66.1M | 20% |
| Segment Reporting Reconciling Item Other | $63.2M | 19% |
| Other | $63.1M | 19% |
CRVL
| Patient Management Services | $146.1M | 62% |
| Network Solutions Services | $89.6M | 38% |
